Wilms Tumor Protein (WT33 or WT1) Overviewed for Pipeline Assessment and Development- H1 2017
Albany, New York, 2017-Jul-10 — /EPR Network/ — The Wilms tumor protein has the tumor suppression property that makes it popular. Hence, the therapeutic development [read full press release…]
